Positron Emission Tomography Using a GRPR Antagonist (68)Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.

about

Positron Emission Tomography Using a GRPR Antagonist (68)Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.

Item

http://www.wikidata.org/entity/Q50083619

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Positron Emission Tomography U ...... and Prostate Cancer Patients.

@en

Positron Emission Tomography Using a GRPR Antagonist

@nl

type

Item

label

Positron Emission Tomography U ...... and Prostate Cancer Patients.

@en

Positron Emission Tomography Using a GRPR Antagonist

@nl

prefLabel

Positron Emission Tomography U ...... and Prostate Cancer Patients.

@en

Positron Emission Tomography Using a GRPR Antagonist

@nl

P1476

Positron Emission Tomography U ...... and Prostate Cancer Patients.

@en

P2093

Fang Li

http://www.w3.org/2001/XMLSchema#string

Gang Niu

http://www.w3.org/2001/XMLSchema#string

Guozhu Hou

http://www.w3.org/2001/XMLSchema#string

Huanwen Wu

http://www.w3.org/2001/XMLSchema#string

Jingjing Zhang

http://www.w3.org/2001/XMLSchema#string

Libo Chen

http://www.w3.org/2001/XMLSchema#string

Lixin Lang

http://www.w3.org/2001/XMLSchema#string

Xingrong Fan

http://www.w3.org/2001/XMLSchema#string

Zhaohui Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

Global cancer statistics, 2012

In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging

F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.

Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET.

68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.

Development and experimental medicine applications of PET in oncology: a historical perspective.

Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.

P31

scholarly article

P356

10.2967/JNUMED.117.198929

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Xiaoyuan Chen

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29123014

http://www.w3.org/2001/XMLSchema#string

P932

6004560

http://www.w3.org/2001/XMLSchema#string